The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Viral Vectored Vaccine Market Research Report 2025
Synopsis
The global Veterinary Viral Vectored Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 551%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Viral Vectored Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Viral Vectored Vaccine.
Report Scope
The Veterinary Viral Vectored Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Viral Vectored Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Viral Vectored Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer-Ingelheim
Ceva
Segment by Type
Alphaherpesvirus (HVT) Vector
Canarypox Vector
Vaccinia Vector
Segment by Application
Pet
Chicken
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Viral Vectored Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Viral Vectored Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Veterinary Viral Vectored Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 551%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Viral Vectored Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Viral Vectored Vaccine.
Report Scope
The Veterinary Viral Vectored Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Viral Vectored Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Viral Vectored Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer-Ingelheim
Ceva
Segment by Type
Alphaherpesvirus (HVT) Vector
Canarypox Vector
Vaccinia Vector
Segment by Application
Pet
Chicken
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Viral Vectored Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Viral Vectored Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Veterinary Viral Vectored Vaccine Market Overview
1.1 Product Overview and Scope of Veterinary Viral Vectored Vaccine
1.2 Veterinary Viral Vectored Vaccine Segment by Type
1.2.1 Global Veterinary Viral Vectored Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Alphaherpesvirus (HVT) Vector
1.2.3 Canarypox Vector
1.2.4 Vaccinia Vector
1.3 Veterinary Viral Vectored Vaccine Segment by Application
1.3.1 Global Veterinary Viral Vectored Vaccine Market Value by Application: (2024-2030)
1.3.2 Pet
1.3.3 Chicken
1.3.4 Others
1.4 Global Veterinary Viral Vectored Vaccine Market Size Estimates and Forecasts
1.4.1 Global Veterinary Viral Vectored Vaccine Revenue 2019-2030
1.4.2 Global Veterinary Viral Vectored Vaccine Sales 2019-2030
1.4.3 Global Veterinary Viral Vectored Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Viral Vectored Vaccine Market Competition by Manufacturers
2.1 Global Veterinary Viral Vectored Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Viral Vectored Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Viral Vectored Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Product Type & Application
2.7 Veterinary Viral Vectored Vaccine Market Competitive Situation and Trends
2.7.1 Veterinary Viral Vectored Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Viral Vectored Vaccine Players Market Share by Revenue
2.7.3 Global Veterinary Viral Vectored Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Viral Vectored Vaccine Retrospective Market Scenario by Region
3.1 Global Veterinary Viral Vectored Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Viral Vectored Vaccine Global Veterinary Viral Vectored Vaccine Sales by Region: 2019-2030
3.2.1 Global Veterinary Viral Vectored Vaccine Sales by Region: 2019-2024
3.2.2 Global Veterinary Viral Vectored Vaccine Sales by Region: 2025-2030
3.3 Global Veterinary Viral Vectored Vaccine Global Veterinary Viral Vectored Vaccine Revenue by Region: 2019-2030
3.3.1 Global Veterinary Viral Vectored Vaccine Revenue by Region: 2019-2024
3.3.2 Global Veterinary Viral Vectored Vaccine Revenue by Region: 2025-2030
3.4 North America Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.4.1 North America Veterinary Viral Vectored Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Viral Vectored Vaccine Sales by Country (2019-2030)
3.4.3 North America Veterinary Viral Vectored Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.5.1 Europe Veterinary Viral Vectored Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Viral Vectored Vaccine Sales by Country (2019-2030)
3.5.3 Europe Veterinary Viral Vectored Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Viral Vectored Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Viral Vectored Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.7.1 Latin America Veterinary Viral Vectored Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Viral Vectored Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Viral Vectored Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Viral Vectored Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Viral Vectored Vaccine Sales by Type (2019-2030)
4.1.1 Global Veterinary Viral Vectored Vaccine Sales by Type (2019-2024)
4.1.2 Global Veterinary Viral Vectored Vaccine Sales by Type (2025-2030)
4.1.3 Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Viral Vectored Vaccine Revenue by Type (2019-2030)
4.2.1 Global Veterinary Viral Vectored Vaccine Revenue by Type (2019-2024)
4.2.2 Global Veterinary Viral Vectored Vaccine Revenue by Type (2025-2030)
4.2.3 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Viral Vectored Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Viral Vectored Vaccine Sales by Application (2019-2030)
5.1.1 Global Veterinary Viral Vectored Vaccine Sales by Application (2019-2024)
5.1.2 Global Veterinary Viral Vectored Vaccine Sales by Application (2025-2030)
5.1.3 Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Viral Vectored Vaccine Revenue by Application (2019-2030)
5.2.1 Global Veterinary Viral Vectored Vaccine Revenue by Application (2019-2024)
5.2.2 Global Veterinary Viral Vectored Vaccine Revenue by Application (2025-2030)
5.2.3 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Viral Vectored Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim
6.1.1 Boehringer-Ingelheim Corporation Information
6.1.2 Boehringer-Ingelheim Description and Business Overview
6.1.3 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product Portfolio
6.1.5 Boehringer-Ingelheim Recent Developments/Updates
6.2 Ceva
6.2.1 Ceva Corporation Information
6.2.2 Ceva Description and Business Overview
6.2.3 Ceva Veterinary Viral Vectored Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Veterinary Viral Vectored Vaccine Product Portfolio
6.2.5 Ceva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Viral Vectored Vaccine Industry Chain Analysis
7.2 Veterinary Viral Vectored Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Viral Vectored Vaccine Production Mode & Process
7.4 Veterinary Viral Vectored Vaccine Sales and Marketing
7.4.1 Veterinary Viral Vectored Vaccine Sales Channels
7.4.2 Veterinary Viral Vectored Vaccine Distributors
7.5 Veterinary Viral Vectored Vaccine Customers
8 Veterinary Viral Vectored Vaccine Market Dynamics
8.1 Veterinary Viral Vectored Vaccine Industry Trends
8.2 Veterinary Viral Vectored Vaccine Market Drivers
8.3 Veterinary Viral Vectored Vaccine Market Challenges
8.4 Veterinary Viral Vectored Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Veterinary Viral Vectored Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Veterinary Viral Vectored Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Veterinary Viral Vectored Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Veterinary Viral Vectored Vaccine Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Veterinary Viral Vectored Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Veterinary Viral Vectored Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Veterinary Viral Vectored Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Veterinary Viral Vectored Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Viral Vectored Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Viral Vectored Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Viral Vectored Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Viral Vectored Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Veterinary Viral Vectored Vaccine Sales by Region (2019-2024) & (Units)
Table 18. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Veterinary Viral Vectored Vaccine Sales by Region (2025-2030) & (Units)
Table 20. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Veterinary Viral Vectored Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Veterinary Viral Vectored Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Veterinary Viral Vectored Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Veterinary Viral Vectored Vaccine Sales by Country (2019-2024) & (Units)
Table 27. North America Veterinary Viral Vectored Vaccine Sales by Country (2025-2030) & (Units)
Table 28. North America Veterinary Viral Vectored Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Veterinary Viral Vectored Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Veterinary Viral Vectored Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Veterinary Viral Vectored Vaccine Sales by Country (2019-2024) & (Units)
Table 32. Europe Veterinary Viral Vectored Vaccine Sales by Country (2025-2030) & (Units)
Table 33. Europe Veterinary Viral Vectored Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Veterinary Viral Vectored Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Veterinary Viral Vectored Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Veterinary Viral Vectored Vaccine Sales by Country (2019-2024) & (Units)
Table 42. Latin America Veterinary Viral Vectored Vaccine Sales by Country (2025-2030) & (Units)
Table 43. Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Veterinary Viral Vectored Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Veterinary Viral Vectored Vaccine Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Veterinary Viral Vectored Vaccine Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Veterinary Viral Vectored Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Viral Vectored Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Veterinary Viral Vectored Vaccine Sales (Units) by Type (2019-2024)
Table 51. Global Veterinary Viral Vectored Vaccine Sales (Units) by Type (2025-2030)
Table 52. Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Veterinary Viral Vectored Vaccine Sales (Units) by Application (2019-2024)
Table 61. Global Veterinary Viral Vectored Vaccine Sales (Units) by Application (2025-2030)
Table 62. Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Boehringer-Ingelheim Corporation Information
Table 71. Boehringer-Ingelheim Description and Business Overview
Table 72. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product
Table 74. Boehringer-Ingelheim Recent Developments/Updates
Table 75. Ceva Corporation Information
Table 76. Ceva Description and Business Overview
Table 77. Ceva Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ceva Veterinary Viral Vectored Vaccine Product
Table 79. Ceva Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Veterinary Viral Vectored Vaccine Distributors List
Table 83. Veterinary Viral Vectored Vaccine Customers List
Table 84. Veterinary Viral Vectored Vaccine Market Trends
Table 85. Veterinary Viral Vectored Vaccine Market Drivers
Table 86. Veterinary Viral Vectored Vaccine Market Challenges
Table 87. Veterinary Viral Vectored Vaccine Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Viral Vectored Vaccine
Figure 2. Global Veterinary Viral Vectored Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Veterinary Viral Vectored Vaccine Market Share by Type in 2023 & 2030
Figure 4. Alphaherpesvirus (HVT) Vector Product Picture
Figure 5. Canarypox Vector Product Picture
Figure 6. Vaccinia Vector Product Picture
Figure 7. Global Veterinary Viral Vectored Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Veterinary Viral Vectored Vaccine Market Share by Application in 2023 & 2030
Figure 9. Pet
Figure 10. Chicken
Figure 11. Others
Figure 12. Global Veterinary Viral Vectored Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Veterinary Viral Vectored Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Veterinary Viral Vectored Vaccine Sales (2019-2030) & (Units)
Figure 15. Global Veterinary Viral Vectored Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 16. Veterinary Viral Vectored Vaccine Report Years Considered
Figure 17. Veterinary Viral Vectored Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Veterinary Viral Vectored Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Veterinary Viral Vectored Vaccine Players: Market Share by Revenue in 2023
Figure 20. Veterinary Viral Vectored Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Veterinary Viral Vectored Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Veterinary Viral Vectored Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. United States Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Veterinary Viral Vectored Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Veterinary Viral Vectored Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Veterinary Viral Vectored Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Veterinary Viral Vectored Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Veterinary Viral Vectored Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Veterinary Viral Vectored Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Veterinary Viral Vectored Vaccine by Type (2019-2030)
Figure 56. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Veterinary Viral Vectored Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Veterinary Viral Vectored Vaccine by Application (2019-2030)
Figure 59. Global Veterinary Viral Vectored Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 60. Veterinary Viral Vectored Vaccine Value Chain
Figure 61. Veterinary Viral Vectored Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
